FDA Inspection
LANXESS CorporationLANXESS Corporation – FDA Inspection, Sep 12, 2024
Record Details
This FDA Inspection record concerns LANXESS Corporation, with an inspection on September 12, 2024, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · 5864e1f8-ffec-40c3-9967-596db88b0aa7
Inspection Facts
- Inspection number
- 1249142
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of LANXESS Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 14, 2023 | Not classified | Seattle District Office | |
| April 10, 2018 | Not classified | Seattle District Office | |
| January 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2013 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| August 2, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LANXESS Corporation
- FDA Inspection 1203652 - 2023-04-14
- FDA Inspection 1050575 - 2018-04-10
- FDA Inspection 961641 - 2016-01-15
- FDA Inspection 858227 - 2013-12-05
- FDA Inspection 843254 - 2013-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.